Neonatal Spinal Anesthesia: Effects of the Addition of Clonidine

NCT ID: NCT01075490

Last Updated: 2010-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-11-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective, double blinded study investigates spinal anesthesia with or without clonidine added to bupivacaine in newborns. This study is based on duration measurement of spinal anesthesia and cardio respiratory recording during 24h for apnea detection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ex premies and term neonates are two subgroups investigated separately. The overall objective is to validate lengthening of spinal anesthesia in newborns in order to avoid "rescue" general anesthesia that occur in 20-40 % of patients with plain bupivacaine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Anesthesia Neonates

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

prematurely born, bupivacaine, placebo

Group Type PLACEBO_COMPARATOR

clonidine

Intervention Type DRUG

equivalent volume of saline added to bupivacaine, 1 mg/kg as spinal anesthesia

prematurely born, bupivacaine, clonidine

Group Type EXPERIMENTAL

clonidine

Intervention Type DRUG

addition of 1 µg/kg of clonidine to bupivacaine 1 mg/kg as spinal anesthesia

term neonate, bupivacaine, placebo

Group Type PLACEBO_COMPARATOR

clonidine

Intervention Type DRUG

equivalent volume of saline added to bupivacaine, 1 mg/kg as spinal anesthesia

term neonate, bupivacaine, clonidine

Group Type EXPERIMENTAL

clonidine

Intervention Type DRUG

addition of 1 µg/kg of clonidine to bupivacaine 1 mg/kg as spinal anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

clonidine

addition of 1 µg/kg of clonidine to bupivacaine 1 mg/kg as spinal anesthesia

Intervention Type DRUG

clonidine

equivalent volume of saline added to bupivacaine, 1 mg/kg as spinal anesthesia

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newborns less than 60 weeks old post-conceptional, former premature or not
* Newborns requiring inguinal hernia or lower limbs surgery,
* infants needing no more critical care assistance
* Informed consent of parents

Exclusion Criteria

* Spinal malformation,
* Coagulopathy,
* critical hemodynamics,
* uncontrolled neurologic or metabolic pathology.
* infection at injection point.
Maximum Eligible Age

60 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University Hospital of Montpellier

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xavier Capdevila, PhD

Role: STUDY_CHAIR

CHU de Montpellier, France

Alain Rochette, MD

Role: PRINCIPAL_INVESTIGATOR

CHU de Montpellier, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Montpellier

Montpellier, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alain Rochette, MD

Role: CONTACT

(33)467338256

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alain Rochette, MD

Role: primary

(33)467338256

References

Explore related publications, articles, or registry entries linked to this study.

Rochette A, Raux O, Troncin R, Dadure C, Verdier R, Capdevila X. Clonidine prolongs spinal anesthesia in newborns: a prospective dose-ranging study. Anesth Analg. 2004 Jan;98(1):56-59. doi: 10.1213/01.ANE.0000093229.17729.6C.

Reference Type BACKGROUND
PMID: 14693584 (View on PubMed)

Rochette A, Troncin R, Raux O, Dadure C, Lubrano JF, Barbotte E, Capdevila X. Clonidine added to bupivacaine in neonatal spinal anesthesia: a prospective comparison in 124 preterm and term infants. Paediatr Anaesth. 2005 Dec;15(12):1072-7. doi: 10.1111/j.1460-9592.2005.01664.x.

Reference Type BACKGROUND
PMID: 16324026 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UF7874

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NAS Treatment - Opiate Versus Non-Opiate
NCT01734551 COMPLETED PHASE4